Literature DB >> 2428033

Cyclosporin A prevents induction of the interleukin 2 receptor gene in cultured murine thymocytes.

J F Gauchat, E W Khandjian, R Weil.   

Abstract

Blast formation and mitotic activation of G0-arrested mouse thymocytes were triggered by the addition of concanavalin A plus interleukin 2 (IL-2) to the culture medium. When added alone, Con A induces within 6 hr a complex reprogramming ("priming") that comprises the activation of the IL-2 receptor gene. The primed thymocytes are competent to interact with IL-2 and to respond to its growth-promoting effect, which corresponds to blast formation and mitotic activation. Cyclosporin A, an immunosuppressive cyclic peptide of fungal origin, prevents in T lymphocytes the activation of a set(s) of genes encoding lymphokines and the IL-2 receptor but does not affect their expression once they have been activated. The biomedical implications of these observations are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428033      PMCID: PMC386517          DOI: 10.1073/pnas.83.17.6430

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

2.  UV crosslinking of RNA to nylon membrane enhances hybridization signals.

Authors:  E W Khandjian
Journal:  Mol Biol Rep       Date:  1986       Impact factor: 2.316

3.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

4.  Molecular weight estimation and separation of ribonucleic acid by electrophoresis in agarose-acrylamide composite gels.

Authors:  A C Peacock; C W Dingman
Journal:  Biochemistry       Date:  1968-02       Impact factor: 3.162

5.  Studies on the mechanism of action of cyclosporin A.

Authors:  D Wiesinger; J F Borel
Journal:  Immunobiology       Date:  1980-01       Impact factor: 3.144

6.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

7.  Functional and molecular characteristics of T-cell growth factor.

Authors:  K A Smith; P E Baker; S Gillis; F W Ruscetti
Journal:  Mol Immunol       Date:  1980-05       Impact factor: 4.407

8.  Inhibition of mitogen-induced lymphokine production by cyclosporin A.

Authors:  L H Block; W Siegenthaler; J Drews
Journal:  Klin Wochenschr       Date:  1980-07-15

9.  Thymoma production of T cell growth factor (Interleukin 2).

Authors:  J J Farrar; J Fuller-Farrar; P L Simon; M L Hilfiker; B M Stadler; W L Farrar
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

10.  Simian virus 40 and polyoma virus stimulate overall cellular RNA and protein synthesis.

Authors:  E W Khandjian; J M Matter; N Léonard; R Weil
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

View more
  10 in total

1.  Cyclosporin A prevents the in vivo development of murine prothymocytes from uncommitted (Thy-1-) precursor cells.

Authors:  R D Huby; G Janossy; I A Lampert
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

2.  Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.

Authors:  B M Foxwell; J Simon; J J Herrero; D Taylor; G Woerly; D Cantrell; B Ryffel
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

3.  In vitro and in vivo action of cyclosporin A on the induction of human interleukin-2 receptor alpha and beta chains.

Authors:  S Caillat-Zucman; L Chatenoud; J F Bach
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

Review 4.  Recent advances in cyclosporine drug delivery: challenges and opportunities.

Authors:  Dhrumi Patel; Sarika Wairkar
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 4.617

Review 5.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

6.  Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury.

Authors:  L Jonasson; J Holm; G K Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  Effects of cyclosporin A on expression of IL-2 and IL-2 receptors in normal and multiple sclerosis patients.

Authors:  V L Calder; A S Bellamy; S Owen; C Lewis; P Rudge; A N Davison; M Feldmann
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

8.  The basis for TCR-mediated regulation of the IL-2 receptor alpha chain gene: role of widely separated regulatory elements.

Authors:  Hyoung-Pyo Kim; Warren J Leonard
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

9.  Lymphokine gene expression in vivo is inhibited by cyclosporin A.

Authors:  A Granelli-Piperno
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

10.  The interleukin 2 receptor alpha chain/CD25 promoter is a target for nuclear factor of activated T cells.

Authors:  K Schuh; T Twardzik; B Kneitz; J Heyer; A Schimpl; E Serfling
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.